Search
for
Sort by
Research 841–870 of 1000+
- A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs
- Biochemical and trichological characterization of diffuse alopecia in women
- A Simple Screening Approach for Assessing Community Prevalence and Phenotype of Polycystic Ovary Syndrome in a Semiurban Population in Sri Lanka
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Androgen excess is the key element in polycystic ovary syndrome
- Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss
- Skin ageing
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS
- The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- Telogen effluvium
- Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies
- Androgen receptors and their biology
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- A Randomized Trial of Oral DHEA Treatment for Sexual Function, Well-Being, and Menopausal Symptoms in Postmenopausal Women with Low Libido
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Systematic approach to hair loss in women
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Nanotechnology-Based Cosmetics for Hair Care
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Androgens and Antiandrogens
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Androgen modulation of Wnt/β-catenin signaling in androgenetic alopecia
- Redefining hormone resistance in prostate cancer
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients